IP Library Granted Patent US 10,508,977
Granted Patent B2
US 10,508,977 · App. 15/357,872 · Granted Dec 17, 2019

Wash solution and method to remediate lubricant contamination

Inventors: Erin Coffman (Nashua, NH); Steven Hecht (Boston, MA); Paul MacLean (Westborough, MA)
Assignee: HOLOGIC, INC.
G01N1/34A01N1/00C12N5/0682G01N1/286C08L33/08C12N5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,508,977
App. No.
15/357,872
Granted
Dec 17, 2019
Kind
B2
Abstract

A wash solution for remediating lubricant contamination in cytological specimens includes a Tris-based alkaline buffer solution. The buffer solution may be prepared in methanol, and may include a proton-rich protein, or a basic amino acid, such as arginine, lysine, or guanidine. A method for remediating a specimen contaminated with lubricant includes using the wash solution and/or adding a salt to the final vial prior to preparing the microscope slide. The method may include adding the wash solution to the specimen, centrifuging the specimen and wash solution to form a supernatant and cell pellet, decanting the supernatant, and adding a preservative solution to the cell pellet. The method may further include adding salt to a vial containing the preservative solution and cell pellet.

Claims (14)

1. A method for removing lubricant contamination from a cytological specimen sample suspended in a collection preservative solution, the method comprising:

pelletizing the specimen;

decanting the collection preservative solution to isolate the pelleted specimen;

adding a wash solution to the pelleted specimen, wherein the wash solution comprises a Tris-based alkaline buffer and a basic amino acid;

centrifuging the specimen and wash solution to form a supernatant and cell pellet;

decanting the supernatant to isolate the cell pellet; and

adding a replacement preservative solution to the cell pellet.

2. The method of claim 1 , wherein the buffer is prepared in methanol.

3. The method of claim 2 , wherein the buffer is prepared in 20% methanol.

4. The method of claim 1 , further comprising adding a salt to the replacement preservative solution and cell pellet.

5. The method of claim 4 , wherein the salt comprises NaCl.

6. The method of claim 1 , wherein the basic amino acid comprises arginine or lysine.

7. The method of claim 4 , wherein adding the salt comprises adding a preservative solution that comprises salt.

8. The method of claim 1 , wherein the wash solution further comprises guanidine.

Assignments (6)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 041050/0285 Recorded Apr 23, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED
Reel/Frame 075455/0001 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2017
From: COFFMAN, ERIN; HECHT, STEVEN; MACLEAN, PAUL
To: HOLOGIC, INC.
Reel/Frame 042531/0245 →
SECURITY INTEREST Recorded Jan 23, 2017
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041050/0285 →
Continuity (1)
Related Publication 20180143114A1 · May 24, 2018